Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study
Thomas Marjot(Oxford Centre for Diabetes, Endocrinology and Metabolism), Gwilym J. Webb(University of Cambridge), Ahad Eshraghian(Sina Hospital), Nneka N. Ufere(Massachusetts General Hospital), Emma Avitabile(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Feng Su(University of Washington), M.-A Catana(Beth Israel Deaconess Medical Center), Ignacio García‐Juárez(Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán), Carolyn Mercer(University of Oxford), Charmaine Matthews(University of Liverpool), Patricia D. Jones(University of Miami), Jonathan Cook(Nuffield Orthopaedic Centre), Matthew J. Armstrong(Queen Elizabeth University Hospital), Eleanor Barnes(Oxford Health NHS Foundation Trust), Ming‐Hua Zheng(Wenzhou Medical University), George Mells(Cambridge University Hospitals NHS Foundation Trust), A. Sidney Barritt(University of North Carolina at Chapel Hill), Costica Aloman(Icahn School of Medicine at Mount Sinai), Sherief Abd‐Elsalam(University of Washington), Ponni Perumalswami(Icahn School of Medicine at Mount Sinai), Renumathy Dhanasekaran(Stanford University), Erica J. Brenner(University of North Carolina Health Care), Upkar S. Gill(Queen Mary University of London), Tamsin Cargill(University of Oxford), Yu Jun Wong(National University of Singapore), Xialong Qi(First Hospital of Lanzhou University), James Kennedy(University of Oxford), Elisa Pose(Hospital Clínic de Barcelona), Aileen Marshall(The Royal Free Hospital), Andrew M. Moon(University of North Carolina at Chapel Hill)
Cited by 525
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
|JAMA Oncology|2021|2k
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
|Gastroenterology|2018|1.7k
Global distribution and prevalence of hepatitis C virus genotypes
|Hepatology|2014|1.6k